C4 Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.8M | $389.6M | $76.1M |
| FY2022 | $9.2M | $289.2M | $29.8M |
| FY2023 | $0 | $246.1M | $126.6M |
| FY2024 | — | $216.0M | $55.5M |
| FY2025 | — | $256.6M | $74.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.8M | $389.6M | $76.1M |
| FY2022 | $9.2M | $289.2M | $29.8M |
| FY2023 | $0 | $246.1M | $126.6M |
| FY2024 | — | $216.0M | $55.5M |
| FY2025 | — | $256.6M | $74.6M |